---
Free space for your campaign:
Order

Welcome to licensed pharmacies in Poland:

Non-prescription medicines delivery across Europe.

Frequently ordered: potency boosters (sildenafil OTC), quit smoking aids.

Gosiaaaa (Anonymous, 188.33.248.) Warszawa 3 years ago

Can breast cancer and spotting be caused by the use of Drovelis?

I take tablets 20 days drovelis . For 3 days my breast hurts today I was in the emergency room and it turns out that there is a small tumor. And on top of that, I've already started staining. Can it be from tablets

1 answer

* required field

You can drag the photo file here.

* required field

Notify of a new answer.
Other messages will not be sent.

Suggested Products

Space for your product

Your product would fit here?
Your product would fit here?

Set up a sponsored products campaign yourself:

Check
Aleksandra Berdys

Aleksandra Berdys Pharmacist

3 years ago

There are no significant indications that Drovelis significantly increases the risk of breast cancer compared to other hormonal contraceptives. Indeed, the use of hormonal contraception with ethinyl estradiol carries a slightly increased relative risk of breast cancer - but this is still a very rare phenomenon. According to the manufacturer, "Because breast cancer is rare in women under the age of 40, the increased number of breast cancer diagnoses in women currently or in the past using combined hormonal contraception is relatively small compared to the overall risk of breast cancer. A causal relationship with the use of combined hormonal contraceptives is not known." I enclose links to helpful materials: https://www.gdziepolek.pl/artykuly/czy-bac-sie-dzialan-niepozadanych-lekow https://www.gdziepolek.pl/artykuly/antykoncepcja-hormonalna

Appreciate the answerer and highlight the question on the home page
User questions and answers that provide feedback about products are not verified for the purchase or use of the product. Companies often order anonymous comments to form positive opinions about their products, or negative ones about competitors. Therefore, be guided by the information in the pharmacists' responses in the first place.

Categories

Specialists